Report cover image

Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry

Publisher GlobalData
Published Apr 17, 2025
Length 14 Pages
SKU # GBDT20043818

Description

Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry

Summary

Within the first 100 days of the current US Administration, there have been a series of changes in the US that will impact the pharmaceutical industry.

To date, key outcomes have included -
  • Leadership changes across the Department of Health and Human Services (HHS)
  • Major cuts across key departments and health programs
  • Additional regulations that may curb investments
  • Introduction of a reciprocal tariff framework
  • Significant tariffs on strategic sectors such as steel, aluminum, and automotive and potential tariffs on pharmaceuticals
  • Heightened tensions between the US and China
Scope
  • This report examines the transition of the 47th U.S. Administration toward a protectionist trade policy during its first 100 days.
  • The analysis focuses on efforts to reduce the trade deficit while assessing the broader implications for domestic industry and global trade relations.

Table of Contents

14 Pages
Introduction
Impact of Geopolitical Changes and Macroeconomics on Pharma
Leadership: Key Departmental Changes Will Have Significant Impact on Pharma Industry and Patients
Reduced Funding and Staff Cuts: ~10,000 Employees Fired Across Healthcare Departments and $250 Million in Cuts in NIH Funding
New Regulations and Policies
China Impact and Innovation Boost
Tariffs
Revitalization of the Biotech Industry to Support Innovation
About GlobalData
Contact us

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.